Category: Billing & Reimbursement

SNMMI Reacts to CMS Coverage Decision on New Alzheimer’s Therapy

On Tuesday, January 11, the Centers for Medicare and Medicaid Services (CMS) announced that it proposes to cover U.S. FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under Coverage with Evidence Development in CMS-approved randomized controlled trials. Here is the SNMMI’s reaction.

Read More

ACR Files “No Surprises” Act Lawsuit

The American College of Radiology (ACR), along with two other associations, has brought a lawsuit against the federal government charging that the interim final rule on surprise medical billing goes against the language of the “No Surprises Act” and will ultimately harm patients and access to care.

Read More